Like
Share
멍실장
아비시니안 신장 아밀로이드증 — 호발 묘종 검진 가이드

Abyssinian Renal Amyloidosis — Screening Guide for Predisposed Breeds

KidneyBreed HealthMeongsiljang Veterinary Advisory Board

Abyssinians are a breed prone to renal amyloidosis, which can begin developing between the ages of 1 and 5. The key is early detection through regular urine and blood tests before proteinuria progresses.

What is Abyssinian renal amyloidosis?

An Abyssinian cat lying calmly on the examination table
Abyssinian renal amyloidosis is a hereditary condition in which abnormal proteins (amyloid) deposit in the kidneys, leading to chronic kidney disease. Veterinary textbooks list amyloidosis as one of the most common hereditary and congenital kidney diseases in cats. The location of the deposits is critical: when amyloid accumulates in the glomeruli, proteinuria is clearly evident, but when it primarily deposits in the medulla or interstitium, proteinuria may be minimal or absent. Therefore, relying solely on urinalysis can result in missed diagnoses, making it essential to monitor blood kidney markers such as SDMA and creatinine alongside regular urinalysis. When pet owners are informed and commit to consistent testing, they can detect changes earlier and begin management strategies to reduce kidney strain sooner.

Why does it occur frequently in Abyssinians?

Feline renal amyloidosis is a well-known hereditary and congenital kidney disease, with textbooks citing Abyssinian and Siamese cats as the most commonly affected breeds. In 1984, Boyce and colleagues first reported familial renal amyloidosis in Abyssinians, followed by subsequent cases where siblings from the same lineage were diagnosed together. Although a single causative gene has not been fully identified, the condition is clearly familial; therefore, if you know the kidney screening history of your cat’s parents or siblings, you can better assess your own cat’s risk. For cats closely related to the Abyssinian breed, it is advisable to pay close attention to their family medical history.

Four predisposed conditions to monitor in Abyssinians

In addition to renal amyloidosis, there are other hereditary and breed-predisposed conditions worth monitoring.
Renal amyloidosis: Amyloid proteins deposit in the glomeruli or renal interstitium, leading to proteinuria and chronic kidney disease. Depending on the site of deposition, proteinuria may be pronounced or minimal.
Progressive retinal atrophy: A hereditary eye disease in which retinal photoreceptors gradually degenerate, potentially resulting in night blindness and blindness.
Pyruvate kinase deficiency: A hereditary condition caused by a deficiency of red blood cell enzymes, which can lead to chronic anemia. Genetic testing is available for diagnosis.
Tooth resorptive lesions: The tooth root is resorbed, which can cause pain and decreased appetite.
The risk for each condition is best assessed through family history review and regular veterinary check-ups.
An illustration highlighting a cat's kidneys and teeth.

Go to the vet immediately if you see these signs

If any of the following symptoms persist for more than 24 hours or worsen suddenly, emergency veterinary care is necessary. Your pet may drink significantly more water than usual or experience a sudden increase in urine output. Loss of appetite and rapid weight loss may occur. Repeated vomiting and an ammonia-like odor from the mouth are also concerning signs. Pale gums or labored breathing can indicate serious distress. If these symptoms appear in a pet already diagnosed with proteinuria, it may suggest progression to kidney failure.

Abyssinian regular screening schedule — Age-based guide

Early detection is key, so we recommend starting screenings earlier and more frequently than for other cat breeds.
Under 1 year: Basic health checkup and review of family history from parents and siblings.
1–3 years: Annual urinalysis (urine protein-to-creatinine ratio) and blood tests (SDMA, BUN, creatinine).
3–7 years: Urinalysis and blood tests every six months, along with systolic blood pressure measurement.
7 years and older: Comprehensive examinations every four months and renal ultrasound are recommended.
If the urine protein-to-creatinine ratio rises above the reference range, do not make a diagnosis based on a single result. Additional detailed testing should only be pursued if elevated levels are consistently confirmed on retesting. Because amyloid deposits primarily in the interstitium can result in only mild proteinuria, it is essential to also evaluate blood-based kidney markers.
An Abyssinian cat undergoing a kidney ultrasound examination by a veterinarian.

Screening items — What to check and what it reveals

ItemWhat is checkedRecommended interval
Urine protein/creatinine ratio (UPC)Proteinuria from glomerular damageAges 1–3: yearly / 3+: every 6 months
Blood SDMA & creatinineEarly sign of declining renal filtration functionAges 1–3: yearly / 3+: every 6 months
Systolic blood pressureWhether renal hypertension is presentEvery 6 months from age 3
Kidney ultrasoundChanges in kidney size, structure, nodulesAge 7+ or if proteinuria is positive
Kidney biopsy (Congo red stain)Direct confirmation of amyloid depositionOnly when clinically suspected or for research purposes

The interval and items may be adjusted at the veterinarian's discretion.

Diagnosis — How is it confirmed?

Diagnosing amyloidosis based solely on clinical signs is challenging, so a step-by-step approach is necessary. First, we assess the degree of proteinuria through urinalysis and monitor creatinine, SDMA, and BUN levels via blood tests. Blood pressure measurement and renal ultrasound are used to evaluate changes in kidney size and structure. While definitive diagnosis requires a kidney biopsy with Congo red staining to directly confirm amyloid deposition, this method carries the burden of anesthesia; therefore, it is more common in clinical practice to manage and monitor the condition using indirect indicators.

Treatment and management — How does it proceed?

Unfortunately, there is no cure for amyloidosis, so our goal is to slow disease progression and reduce the burden on the kidneys.
Renal prescription diet: A diet formulated with controlled levels of protein, phosphorus, and sodium helps reduce stress on the glomeruli.
Blood pressure management: Your veterinarian will determine the appropriate medication and dosage based on your pet’s weight and blood pressure. RAAS inhibitors may also be used if proteinuria is present.
Adequate hydration: Use automatic water fountains and wet food to help prevent dehydration.
Supportive nutritional management: Adjunct therapies, such as omega-3 fatty acids, should be used only under veterinary guidance and at recommended dosages.
Regular monitoring: Tracking kidney values every 3–4 months is essential for evaluating disease progression.
A scene featuring kidney prescription food, an automatic water dispenser, and omega-3 supplements.

Checking family history is crucial for breeding and adoption

Abyssinian renal amyloidosis is a condition with clearly documented familial occurrence. Before adopting, be sure to review the kidney screening history of the kitten’s parents and siblings. Responsible breeders will openly share the parents’ proteinuria test results and kidney function values. Kittens already diagnosed with the condition should be excluded from breeding to safeguard the health of the entire breed.

Reviewed by a veterinarian

Dr. Tony — Punnawat Phongkittirak

Dr. Tony — Punnawat Phongkittirak

Veterinarian

A veterinarian who majored in veterinary medicine at Khon Kaen University, Thailand, and completed the IVSA program at North Carolina State University in the United States. Drawing on clinical experience at animal hospitals, he works in the pet healthcare field and is dedicated to building a digital care environment that connects pet parents with veterinarians.

Frequently Asked Questions

My Abyssinian is still young. Does he need a kidney checkup?
Yes, Abyssinians can begin to show kidney changes even at a relatively young age, and amyloid accumulation in the kidneys may lead to mild proteinuria. Therefore, establishing baseline values through annual urine and blood tests starting at one year of age makes it much easier to detect any future changes.
My pet’s proteinuria has slightly increased—should I start a prescription diet right away?
We don’t rely on a single urine protein-to-creatinine ratio result. Instead, we recheck it every 2 to 4 weeks. If the ratio remains consistently elevated, we consider dietary and medical interventions. A veterinarian’s assessment is essential.
Can genetic testing help identify potential issues in advance?
While the single causative gene for Abyssinian renal amyloidosis has not been fully identified, you can assess the risk by checking the family history and conducting a basic health screening at one year of age.
Do Somali cats face the same risks?
The veterinary textbook provided lists Abyssinian and Siamese cats as breeds prone to familial renal amyloidosis. Since Somali cats are closely related to Abyssinians, it’s wise to consider their family history from the same perspective. Please also gather the renal screening records of the cat’s parents and siblings.
Will feeding only a kidney prescription diet stop the progression of the disease?
Prescription diets are one of the tools used to reduce the burden on the kidneys and slow disease progression. However, for optimal results, they must be combined with blood pressure management, adequate hydration, and regular monitoring.

Share

Related Guides

References

[1] Boyce, J.T., DiBartola, S.P., Chew, D.J. et al. (1984). Familial renal amyloidosis in Abyssinian cats. Veterinary Pathology 21: 33–38.

[2] Little, S.E. (Ed.) (2nd Edition). The Cat, Clinical Medicine and Management — Section VII, Population Medicine: Inherited Diseases Common to Domestic Cat Breeds.

[3] Chew, D.J., DiBartola, S.P., Schenck, P.A. Urinalysis in the Dog and Cat — Glomerular Amyloidosis (Congo Red staining).

This information is based on veterinary literature and does not replace diagnosis or treatment. Please consult a veterinarian for specific health concerns.

Metapet Co., Ltd. | CEO: Park Sung-yong | Business Reg. No. 417-88-02562 | Seoul, South Korea | Customer Center

Abyssinian Renal Amyloidosis: Screening for At-Risk Cats | Meongsiljang